Last checked at 31 May 2023 07:00
31 May 2023
Cambridge Cognition Holdings Plc
("Cambridge Cognition" or the "Company")
Capital Markets Day
Cambridge Cognition Holdings plc ("the Company"), which develops and markets digital solutions to assess brain health, is pleased to announce that it will be hosting a Capital Markets Day on 14 June 2023 at 14:00 in the Great Room at Central Court, 25 Southampton Buildings, London WC2A 1AL.
The event will feature a series of presentations from Cambridge Cognition's management and senior leadership team focussing on the latest developments in the Company's product and technology portfolios.
To express interest in attending the event please email: cog@investor-focus.co.uk
No material new information or update on current trading will be disclosed at the event.
Enquiries:
Cambridge Cognition Holdings Plc Matthew Stork, Chief Executive Officer Stephen Symonds, Chief Financial Officer | Tel: 012 2381 0700 press@camcog.com |
Panmure Gordon (UK) Limited(NOMAD and Joint Broker) Freddy Crossley / Emma Earl / Mark Rogers Rupert Dearden | Tel: 020 7886 2500 (Corporate Advisory) (Corporate Broking) |
Dowgate Capital Limited (Joint Broker) David Poutney / James Serjeant | Tel: 020 3903 7715
|
IFC Advisory Limited (Financial PR and IR) Tim Metcalfe / Graham Herring / Zach Cohen | Tel: 020 3934 6630 cog@investor-focus.co.uk |
About Cambridge Cognition
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
For further information visit www.cambridgecognition.com